Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Nicole Walton

Nurse Practitioner, Acute Care Overland Park, KS Nurse Practitioner

NPI 1871992057 CMS profile 11041851

10995 Quivira Rd, Overland Park, KS 66210

Open in the dashboard

General payments

$13,889

286 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicole Walton of Overland Park, KS is reported in the CMS Open Payments database as having received $13,889 across 286 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner, Acute Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,555 100
2024 General $2,489 63
2023 General $1,876 47
2022 General $1,659 42
2021 General $1,310 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicole Walton
  • Nurse Practitioner, Acute Care median
  • Middle half of Nurse Practitioner, Acute Care
  • National median

In program year 2025, general payments to Nicole Walton were reported at $6,555. Among 11,827 Nurse Practitioner, Acute Care profiles paid that year, the median was $152 and the middle half received between $48 and $458.

Show as a table
Year Nicole Walton Nurse Practitioner, Acute Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,310 $123 $38–$327 $132
2022 $1,659 $130 $44–$369 $149
2023 $1,876 $144 $49–$410 $160
2024 $2,489 $146 $48–$433 $164
2025 $6,555 $152 $48–$458 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Saluda Medical Americas, Inc. $3,748 35 payments
  2. Boston Scientific Corporation $2,507 65 payments
  3. Abbott Laboratories $1,453 24 payments
  4. Nalu Medical, Inc. $1,306 24 payments
  5. Spinal Simplicity, LLC $1,261 15 payments
  6. Nevro Corp. $981 16 payments
  7. AbbVie, Inc. $516 30 payments
  8. Medtronic, Inc. $360 7 payments
  9. SPR Therapeutics, Inc $321 7 payments
  10. GRT US Holding, Inc. $205 8 payments
  11. Other $1,232 55 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $11,315 277 payments
  2. Travel and Lodging $2,574 9 payments
Products named General payments · program years 2021–2025
  1. Evoke $3,748 35 payments
  2. Nalu Neurostimulation System $1,306 24 payments
  3. HA MINUTEMAN G3-R $1,261 15 payments
  4. WaveWriter Alpha Prime 16 $862 25 payments
  5. PROCLAIM $598 12 payments
  6. Senza $543 8 payments
  7. Omnia $438 8 payments
  8. Superion Indirect Decompression System $425 6 payments
  9. SPRINT PNS System $321 7 payments
  10. UBRELVY $306 21 payments
  11. Other $3,799 124 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 27 drugs

Part D claims

2,276

Median for Nurse Practitioner: 389

Drug cost

$42,141

Median for Nurse Practitioner: $21,885

Branded share of claims

39.4%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 602 $14,073
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 269 $7,016
Oxycodone Hcl Generic 233 $3,796
Pregabalin Generic 133 $3,713
Gabapentin Generic 234 $3,495
Methocarbamol Generic 74 $1,222
Tizanidine Hcl Generic 98 $1,177
Baclofen Generic 78 $974
Duloxetine Hcl Generic 59 $867
Celecoxib Generic 46 $796

The 10 drugs with the highest cost, of 27 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$62,571

Medicare's payments for the services billed

Medicare patients

291

Average age 73

Services billed

2,092

189 women, 102 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 41%
Diabetes 32%
Ischemic heart disease 31%
Chronic kidney disease 24%
COPD 21%
Osteoporosis 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Prialt
  • TerSera Therapeutics LLC $70
$70 — —
BELBUCA
  • Collegium Pharmaceutical, Inc. $49
$49 — —
BOTOX
  • AbbVie, Inc. $25
$25 — —
XTAMPZA
  • Collegium Pharmaceutical, Inc. $17
$17 — —
ZTLido
  • Scilex Pharmaceuticals Inc. $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

286 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Acute Care in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record